Published in
Lippincott, Williams & Wilkins, Journal of Immunotherapy, 1(32), p. 79-85, 2009
DOI: 10.1097/cji.0b013e31818c8aaf
Links
Tools
A Phase 1 Study of Granulocyte Macrophage Colony-stimulating Factor (Sargramostim) and Escalating Doses of Thalidomide in Patients With High-risk Malignant Melanoma:
Journal article published in 2009 by
Jose Lutzky 
,
Robert Weber,
Yvonne Nunez,
Matt Gillett,
Lynn Spitler
,
Robert Weber,
Yvonne Nunez,
Matt Gillett,
Lynn Spitler
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 